Article
Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
Circulation. Arrhythmia and electrophysiology - 1 Mar 2016
Hodgkinson Kathleen A, Howes A J, Boland Paul, Shen Xiou Seegar, Stuckless Susan, Young Terry-Lynn, Curtis Fiona, Collier Ashley, Parfrey Patrick S, Connors Sean P
Abstract excerpt
BACKGROUND: We previously showed a survival benefit of the implantable cardioverter defibrillator (ICD) in males with arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43. We present long-term data (median follow-up 8.5 years) after ICD for primary (PP) and secondary prophylaxis in males and females, determine whether ICD discharges for ventricular tachycardia/ventricular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
